跳至主要内容
临床试验/ISRCTN96104919
ISRCTN96104919已完成2 期

Randomized controlled trial evaluating the efficacy of carrageenan as a topical microbicide against HPV Infection

Canadian Institutes of Health Research (CIHR) (Canada)0 个研究点目标入组 461 人开始时间: 2012年3月7日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
461

研究概览

简要总结

2019 Interim results article in https://pubmed.ncbi.nlm.nih.gov/29684633/ interim results (added 23/10/2020) 2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34487919/ (added 07/09/2021) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37396806/ (added 04/07/2023)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Added 01/03/2017: Current inclusion criteria as of 17/11/2014:
  • 1. Female aged 18 or older living in Montreal
  • 2. Plan to remain in Montreal for at least the next year
  • 3. Have had vaginal sex with a male partner during the last 3 months and expect that they
  • will do so again in the next 3 months, regardless of whether or not the male partner(s) will
  • 4. Not currently in a relationship that has lasted longer than 6 months
  • 5. Be willing to follow study instructions
  • 6. Understand French or English
  • 7. Be willing to comply with follow-up for at least 12 months
  • 8. Have an intact uterus
  • 9. Have no history of cervical lesions/cancer or genital warts
  • 10. Not be pregnant or planning to immediately become pregnant and not currently breastfeeding
  • 11. Not had a recent (within the last 6 weeks) pregnancy, abortion, or genital surgery
  • 12. Be using a medically acceptable method of contraception and intend to use it for the
  • duration of the trial
  • 13. Have no HIV infection
  • 14. Have no known allergy or hypersensitivity to vaginal lubricants
  • 15. Have no allergy to all of the ingredients of the study product or placebo
  • Previous inclusion criteria from 12/09/2013:
  • 1. Female aged 18-29 living in Montreal
  • 2. Plan to remain in Montreal for at least the next year
  • 3. Have had vaginal sex with a male partner during the last 3 months and expect that they will do so again in the next 3 months, regardless of whether or not the male partner(s) will change
  • 4. Not currently in a relationship that has lasted longer than 6 months
  • 5. Be willing to follow study instructions
  • 6. Understand French or English
  • 7. Be willing to comply with follow-up for at least 12 months
  • 8. Have an intact uterus
  • 9. Have no history of cervical lesions/cancer or genital warts
  • 10. Not be pregnant or planning to immediately become pregnant and not currently breast-feeding
  • 11. Not had a recent (within the last 6 weeks) pregnancy, abortion, or genital surgery
  • 12. Be using a medically acceptable method of contraception and intend to use it for the duration of the trial
  • 13. Have no HIV infection
  • 14. Have no known allergy or hypersensitivity to vaginal lubricants
  • 15. Have no allergy to all of the ingredients of the study product or placebo
  • Original inclusion criteria:
  • 1. Female aged 18-24 living in Montreal
  • 2. Plan to remain in Montreal for at least the next year
  • 3. Have had vaginal sex with a male partner during the last 30 days and expect that they will do so again in the next month, regardless of whether or not the male partner(s) will change
  • 4. Not currently in a relationship that has lasted longer than 3 months
  • 5. Be willing to follow study instructions
  • 6. Understand French or English
  • 7. Be willing to comply with follow-up for at least 12 months
  • 8. Have an intact uterus
  • 9. Have no history

排除标准

  • Does not meet inclusion criteria

研究者

发起方
Canadian Institutes of Health Research (CIHR) (Canada)

相似试验

Carrageenan Against Transmission of Cervical Human... | 临床试验